Video Dispatch: COVID’s Last Stand?

The United States has made remarkable progress in vaccinating large swathes of its population since the beginning of the year. Despite near walk-in availability of vaccines across the country, however, a significant portion of the population–nearly 30%–has not receive any dose of available vaccines. 

Infection and mortality rates are dropping precipitously and steadily across all vaccinated groups in the United States. This good news belies the fact that COVID remains as pernicious and deadly (if not more so, thanks to these pesky variants) among unvaccinated Americans. Summertime temperatures, and indoor congregating and shared A/C, will likely see a final surge among unvaccinated Americans in the sunbelt states stretching from California through Georgia before the end of the year. If you have not yet received your vaccine, we here at Zeihan at Geopolitics urge you to do so.

Heck, you might even get a free beer!


If you enjoy our free newsletters, the team at Zeihan on Geopolitics asks you to consider donating to Feeding America.

The economic lockdowns in the wake of COVID-19 left many without jobs and additional tens of millions of people, including children, without reliable food. Feeding America works with food manufacturers and suppliers to provide meals for those in need and provides direct support to America’s food banks.

Food pantries are facing declining donations from grocery stores with stretched supply chains. At the same time, they are doing what they can to quickly scale their operations to meet demand. But they need donations – they need cash – to do so now.

Feeding America is a great way to help in difficult times.

The team at Zeihan on Geopolitics thanks you and hopes you continue to enjoy our work.

DONATE TO FEEDING AMERICA

The Inflating of Fears

I’m going to attempt the impossible with this one: making economics not necessarily fun, but painfully relevant to someone who cannot work an Excel document.
 
Here goes:
 
The United States is experiencing the fastest increase in prices since at least the peak of the subprime boom back in 2008 – in April inflation was already up 4.2% from a year earlier – generating waves of criticism for the Biden administration, whose spending plans are credited with artificially spiking demand. (Normally, the government aims to keep annual increases below 2.0%). At first blush, I really don’t see the April data as a big deal. Everyone remember what was going on a year ago? Coronavirus-induced lockdowns cratered demand, which meant that prices were falling quite a bit. This 4.2% increase from a year earlier is really just a reversion to the mean.
 
But that said, yeah, it is going to get much, much worse over the next year or so.
 
Arguably the single biggest reason for the price increases is that Americans are getting out. The country is now majority vaccinated and since COVID is a respiratory pathogen, it has more difficulty spreading when people are outdoors. Aside from the most introverted of agoraphobes who have loved COVID lockdowns, everyone is jonesing to get out of their home this summer and to some version of “normal”.
 
Market tightness will become particularly noticeable in foodTraditionally, half the food consumed (by value) is eaten outside of the home. A year ago when the lockdowns began, there was simply too much steak and cheese and bacon and not enough flour and chicken and milk. Agricultural production and processing systems contorted to make the adjustment. Now everything is going the opposite direction. There isn’t enough steak and cheese and bacon to support rapidly-shifting demand patterns.
 
Energy is rapidly evolving to match, for reasons typical, atypical, and downright weird. There’s a normal seasonal increase in demand as farmers start planting in March, and as spring breakers hit their “hold my beer” parties. That increase doesn’t typically stop until autumn. So cyclically, we’re on the “normal” early part of the demand ramp up. And it is happening as Americans are starting to get back to their lives and so are driving more. And we have summer car vacation season just around the corner that pretty much everyone is looking forward to. Hell, am planning a road trip. I hate road trips and yet I. Cannot. Wait!
 
On top of that we’ve had a few hiccups across the energy sphere. A container ship clogged the Suez Canal for a week, blocking about 10% of global energy flows. Texas had a freak freeze that took some 3 million barrels of crude production – over 20% of US output – offline for a couple weeks, along with all the downstream refining and petrochemical work that actually brings us usable products like plastics and diapers and tires and cosmetics and…face masks. Russian hacker group DarkSide took down the Colonial Pipeline for nearly as long, interrupting gasoline flows to half the Eastern Seaboard. A new, horrific COVID wave in India is threatening port operations, potentially impacting half the country’s oil supply. Individually, each is an event of global significance. Together? Damn.
 
Nor are Americans staying put. The Boomers, America’s largest-ever generation, are moving to warmer locales as they retire en masse. The Millennials, America’s second-largest-ever generation, are moving away from the major coastal cities to places where they can afford single-family homes so they can raise their new families. No one wants to be in a bus or subway everyday where they might be exposed to COVID. Collectively, mass relocations are adding huge demand pressures to any and all suburban locations, particularly those in the South, Southwest, and Mountain West.
 
In the world of manufacturing, the pressure is even greater. On the demand side we’ve seen a lot of sloshing around this past year as people in waves decide they all need new computers or phones or home additions or furniture. We’ve not seen this level of erratic consumer behavior in the modern era. The world of global manufactures simply cannot keep up, and retooling to meet demand in one area almost by definition means insufficient supply for another. The issue of the current quarter is surging demand for electronics has meant there are not enough semiconductors available for automobile manufacture. 
 
The broader supply side is a more national issue. American firms, rightly spooked by disruptions physical, political and medical are relocating many of their supply systems to North America to insulate themselves from global disruptions. The shale revolution has made energy costs locally lower than they are globally, while the U.S. workforce’s high productivity has made most manufacturing processes cheaper to operate in North America than East Asia. Of course, the industrial plant first needs to be built, and that absorbs just as many material inputs as expanding the housing stock.
 
There’s also a big risk on the near horizon. If the Biden administration’s signaling bears out, the United States will be boycotting the 2022 Winter Olympics in Beijing. That will turn what is an ongoing trade cold war into a full collapse of economic relations. Every American firm operating in China will need to decamp, either because the Chinese confiscate everything as punishment or because their competitors start slapping them with the label of “sponsors of the Genocide Olympics”. We probably are only seeing the tip of the proverbial iceberg in terms of relocation-driven manufacturing price pressures.
 
So far, Americans don’t care about the price increases, and they aren’t likely to soon. If you fear the subway, you will pay a premium to not have to use it. If you do not want to shovel snow, you will pay a premium to not have to do it. If your home improvement project is already three-quarters finished, you will pay a premium to complete it. If your new home office has demonstrated to you that you need a better set of headphones and a newer computer, you will pay a premium to get them. If you have not eaten out in a year, that first time out – the first twenty times out – you are going to have yourself a damn steak. Personally, I find myself in four of these five categories. Add in my shiny new snow blower and I’m in four and a half.

In the remainder of 2021 and throughout 2022 the United States will experience the highest levels of inflation since at least the 1970s. And if relations with the Chinese really do tank, the United States will be looking at World War II levels of price increases.
 
American citizens can afford it. Multiple federal bailout programs by two presidents have put cash in pockets; Americans now have record cash on hand. One often-missed aspect of the most recent COVID mitigation plan is to nearly double the child tax credit, and make half of it pre-paid in monthly installments. Those checks start reaching Americans July 15.
 
American companies can afford it. Those bailout programs benefit American firms just as much as they benefit the American people. Arguably more in some cases. Without them the airlines would have had to ground over half their fleets, and we wouldn’t be nearly half as far along on retooling our industrial plant. Even small firms like ours have benefited. State support not only helped us maintain the staff we’ve spent 15 years building, but even expand a bit. (Incidentally, we hope to have our disaster assistance loan paid back this calendar year. But regardless, everyone say hi to our new researcher!)
 
Collectively, this government spending expansion is the largest since World War II, and it is not the story’s end. The Federal Reserve has expanded the money supply to purchase government debt to pay for all the new spending as well as to purchase bonds on private markets to backstop everything from city spending to corporate spending to the mortgage market to student debt to credit cards.
 
(For those of you who obsess about Fed actions as harbingers of the American Apocalypse or vanguards of the imminent dominance of Bitcoin, curb your enthusiasm. Yes, the Fed has expanded M2 by roughly one-fifth since COVID began to just shy of $20 trillion, and yes that is clearly inflationary. BUT… First, over half that increase was in the first month of COVID. That was over a year ago now, and…no Apocalypse. Second, the U.S. economy is bigger than $20 trillion and the USD is the world’s primary method of exchange and primary store of value, so a moderate monetary expansion just doesn’t get my motor running. Third and most importantly, the Chinese have expanded their money supply to $35 trillion despite their economy being smaller than America’s and very little of the yuan supply being traded internationally. Please obsess about the right thing and adjust your forecasts and plans accordingly.)
 
Between the breaking of a year-long claustrophobic containment and government actions, Americans are gobbling up a whole lot of everything. Rising prices reflect all this.
 
This does not mean the price increases don’t matter, and I’m not limiting the things-that-matter to the normal bugaboos of inflation as regards spending capacity, wealth generation, debt levels, income stress, and mid-term economic growth trajectories. The country – the world – is changing, and inflation is hitting us all a bit differently than before.
 
First, a lot of jobs that existed pre-COVID are simply gone. COVID gave many firms no option but to automate away as many manhours as possible. McDonalds and Pizza Hut have practically turned into Sonic. Now that the recovery is underway, but income support has not stopped, folks who used to earn less than $16 an hour are either waiting for benefits to run out or looking for jobs with better compensation. That’s nudging employers with lower-pay positions to automate more. Most of what few of those jobs might have survived COVID will not survive the recovery.
 
COVID also encouraged online shopping to a degree and for a duration which suggests most retail locations will simply not recover. The jobs lost in the retail sector are among people on the low-end of the income spectrum, disproportionately impacting women, Blacks and Hispanics. The most impacted individuals are those who have the lowest education levels and the most difficulty adapting to changed circumstances. They are also the people least able to function in a higher-inflation environment. America’s inequality issues are on the cusp of becoming far, far worse. We can look forward to that being reflected in American politics throughout this next political cycle. More Trumps. More Sanders.
 
Second, the inequality issue isn’t simply within the United States, but between the United States and the rest of the world. The United States will largely be finished with its vaccination program in about a month, enabling it to experience the fastest economic growth of its history. We’re talking in excess of 10% annually. That’s China-doping-statistics sort of growth. The United Kingdom and Israel are finishing their vaccinations on a similar timeframe. Vaccine diplomacyfrom Washington will soon flood Canada and Mexico with more than enough doses to enable them to join the party by the end of August. Europe is unlikely to join in until at least the fourth quarter. More likely year’s end.

And…that’s about it for now. The vaccine formulas that work and that the U.S. will soon have an excess of – Pfizer and Moderna – require two shots and primarily freezer storage, making both broadly unsuitable for the developing world. For most of the world’s population, mass vaccination cannot begin until 2022 and it will be at a much slower rate than what we have seen in America.
 
The timing of all this is beyond unfortunate. Most of the world’s investment capital comes from people who are on the cusp of retirement. They’re shoving every spare dollar, euro, pound or yen they have into their retirement savings. Once they flip into retirement, they never add to their nest egg again. Collectively the Boomer generation of the world is the largest generation our species has ever generated, and they, on average, retire next year. Capital has never been as easy to access or on cheaper terms as it will be in this calendar year.
 
America, and a few other lucky countries, are experiencing this capital surge and record growth at the same time. Such a happy confluence of events is the sort of thing that enables firms and governments to lay down development efforts that will last for decades. I may have a boatload of reservations about all the new spending the Biden administration wants to launch, but I have to admit, if it is going to happen, the time is absolutely now.
 
For the rest of the world, they are missing the last global capital boom of our lives. Most of the global Boomer cadre did not have kids. Which means that as they age they will instead absorb capital from their respective systems in the form of higher health care and pensions costs, while never again paying into those systems. Those costs of capital won’t simply increase by end-2022, they’ll skyrocket. For those of you who don’t understand what “skyrocket” means, increasing the interest rate on your mortgage loan by just 1% means increasing your monthly payment by 20%. Now apply that to everything. Car loans. Credit card debt. Municipal bonds. The federal debt. Everything. By the time the rest of the world emerges from under the pall of coronavirus, it’ll be too late.

The United States, France and New Zealand are the only exceptions to these patterns in the advanced world. The Boomers in those three countries had kids. They’re the people that we know as the Millennials, the oldest of which are now 42. Their consumption is keeping these three systems ticking on, and in about a decade American, French and Kiwi Millennials will become major savers and investors and they will bit by bit regenerate the capital stock in their respective countries. But there are not appreciable numbers of Millennials in any other advanced nation. Add in that the vast bulk of the developing world has experienced baby busts more traumatic than anything that’s happened in the developing world these past five decades and this is pretty much it for capital supplies globally.

Folks, this is it. Globalization is over. Even if the Americans decided that they wanted to continue to patrol the world, even if the Americans could keep making the world safe for international trade, global demographics and global capital tell us the page has already turned. Global aging meant that global consumption and investment was always going to collapse this decade, and then coronavirus moved the end forward. Most countries will never recover economically to where they were at the beginning of 2020 when the health crisis struck. And now countries must deal with the intertwined nightmares of a collapse in global consumption, rising economic nationalism in the small handful of countries that retain decent demographic structures, and a high inflation environment triggered by the American recovery.
 
For me, at least, this simplifies the math. My next book project, scheduled to publish in 2022, was originally going to thread the needle of how various economic sectors will function in the transition from a globalized world to a deglobalized world. History, apparently, has other ideas. It has now sped up. We’ve retooled to focus on ‘life after the end of the world’. Which, now that I’m reading it aloud, might make a pretty good title.


If you enjoy our free newsletters, the team at Zeihan on Geopolitics asks you to consider donating to Feeding America.

The economic lockdowns in the wake of COVID-19 left many without jobs and additional tens of millions of people, including children, without reliable food. Feeding America works with food manufacturers and suppliers to provide meals for those in need and provides direct support to America’s food banks.

Food pantries are facing declining donations from grocery stores with stretched supply chains. At the same time, they are doing what they can to quickly scale their operations to meet demand. But they need donations – they need cash – to do so now.

Feeding America is a great way to help in difficult times.

The team at Zeihan on Geopolitics thanks you and hopes you continue to enjoy our work.

DONATE TO FEEDING AMERICA

Video Dispatch: China’s Demographic Decline

Bit by bit we are getting back to normal. Over half of the American adult population is now vaccinated, and vaccines will soon be available in most locations on a walk-in basis. At current rates, I have little doubt all American adults can be vaccinated by June 1. 

For me personally, that means I am starting to travel again. But the world really doesn’t care where I am. Events happen and I need to get to work. The big news this week is out of China, and it is NOT good.


If you enjoy our free newsletters, the team at Zeihan on Geopolitics asks you to consider donating to Feeding America.

The economic lockdowns in the wake of COVID-19 left many without jobs and additional tens of millions of people, including children, without reliable food. Feeding America works with food manufacturers and suppliers to provide meals for those in need and provides direct support to America’s food banks.

Food pantries are facing declining donations from grocery stores with stretched supply chains. At the same time, they are doing what they can to quickly scale their operations to meet demand. But they need donations – they need cash – to do so now.

Feeding America is a great way to help in difficult times.

The team at Zeihan on Geopolitics thanks you and hopes you continue to enjoy our work.

DONATE TO FEEDING AMERICA

The Ins and Outs of Vaccine Diplomacy

On March 2 the Biden administration announced a vaccine manufacturing partnership between two of the largest and most successful drug manufacturers in the United States: Johnson & Johnson and Merck. Less than a week previous the U.S. FDA approved J&J’s vaccine for emergency use in combatting the COVID-19 virus; its formula will now be produced both in J&J and Merck facilities. (At present neither firm has announced expansion schedules or delivery volumes.)
 
This is big. Of the five proven anti-COVID vaccine formulas that have been approved for use in the First World, only the J&J formula is refrigerator safe and easy to manufacture and a single-dose formula. As such it can be used for inoculations at any facility worldwide that can handle any other vaccine formula. It is this formula that is capable of vaccinating the majority of the world’s population against COVID, and with the Merck tie-up I’ve little doubt the formula will be able to make good on its potential.
 
Again, this is big. The question now becomes just how big?
 
Some backstory:
 
In his early days, the Biden administration activated an option in the Trump administration’s supply contracts with Pfizer and Moderna. Each will now provide the United States with at least 300 million doses by the end of July, providing enough vaccine for 300 million Americans. That alone is enough to cover 90% of the American population, children included. Johnson & Johnson (by itself) will kick in another 100 million by the end of June, and since the J&J formula is single shot, that’s enough for another 100 million people.
 
Such figures suggest every adult in the United States who wants to get the vaccine will be able to get it by June 1, and that on-demand, walk-in vaccinations will be available by mid-April.
 
In fact, this is now the worst-case scenario for vaccine availability in the United States. The manufacturers continue to find ways to optimize their manufacturing. For example, Pfizer has increased their rate of production by more than 80% in just January and February and has simplified its distribution by proving its formula can be stored in normal freezers as opposed to the dry-ice-ultra-cold set-ups it initially used. Such advances likely shaved 4-6 weeks off American vaccination schedules.
 
There are also two other vaccine formulas – AstraZeneca and Novavax – that will likely contribute millions of doses (maybe tens of millions) to the effort, bringing the American schedule ever forward.
 
Best yet, this new J&J-Merck tie up isn’t included in the above prognostications. Despite what my vaccine optimism might suggest, vaccine manufacture isn’t quick. It requires 2-3 months to grow the vaccine cultures in a vat, and then a few more weeks for testing and bottling. And that assumes the facilities are already ready to go. The primary reason the Pfizer and Moderna formulas are moving along so quickly is that they began production last year before they even applied for FDA approval. The J&J-Merck effort is only beginning now. We shouldn’t expect to see first doses from the collaboration in the hands of medical professionals until June.
 
Which raises some very interesting geopolitical possibilities. June 1 is when the United States will have tens of millions of surplus doses from its existing production contracts. The J&J-Merck partnership will add at least 100 million doses on top of that, with many more to come throughout the summer as everyone’s efforts continue to expand. While the bulk of the rest of the world will be starved of vaccine, the United States will have a glut. Since the U.S. government is the entity that contracted for the doses, it will be up to the Biden administration to decide where those doses go.
 
The term you’re looking for is “vaccine diplomacy”.
 
It comes at a fortuitous time. The United States has backed away from the world. This isn’t a Clinton thing or a W Bush thing or an Obama thing or a Trump thing or a Biden thing, but instead a United States thing. The American people lost interest in playing a constructive role in the world three decades ago, and America’s political leadership has molded itself around that fact. Trump may have been instinctually and publicly hostile to all things international, but Biden is only different in tone. Biden’s Buy-American program is actually more anti-globalization than Trump’s America-First rhetoric as it is an express violation of most of America’s international trade commitments. TeamBiden says it wants to reestablish America’s global leadership…but it plans to do so without any troops or money. Sorry, but that’s not how it works.
 
Which makes the possibilities for vaccine diplomacy wildly interesting. The United States has no responsibility to provide COVID vaccines to the world. It can – it will – distribute them, but it will want something in return.

Let’s begin with the obvious decisions:
 
Canada: Like the United States, the Canadian government contracted for more doses than it needed from multiple vaccine developers, working from the wise theory that not all would pan out. Like the United States, several of the firms Canada chose did work out, suggesting a similar vaccine glut. But unlike the United States, no vaccines are manufactured in Canada, so Canadians have had to wait. Not much longer. Whether it is because the United States finishes its vaccination program and so frees up manufacturing capacity for its northern neighbor, or because the Biden administration chooses to apply vaccine diplomacy to its closest friend, Canada will get all the vaccine it needs in June. Considering the Canadian health system is far superior to America’s, mass vaccination in Canada should be completed by July 1.
 
Mexico: America’s southern neighbor lacks both America’s manufacturing capacity and Canada’s health system. It was never going to be among the first countries to achieve mass vaccination. If left it its own devices, that is. In reality, Mexico will be second in line. Mexico is one of America’s two largest trading partners (based on how you run the math). Mexicans are America’s second- or third-largest ethnic group (depending upon how one defines “Mexican”). The Mexican-American border is the most-crossed (legally) in the world (no matter how you count). Completely ignoring health and ethics and good-neighborliness and focusing purely on self-interest, Mexico is the obvious second choice for American vaccine diplomacy. Vaccination there will take longer than Canada. After all, there are 130 million people in Mexico to Canada’s 35 million, and the health system isn’t nearly as advanced. But I’d be surprised if the Mexican effort wasn’t functionally completed – and with it, the broader North American economy recovered – before August 1.
 
After that, the choices become less obvious.
 
The very nature of the vaccines and coronavirus limits the options:
 
China and Russia are out. In addition to the pair becoming increasingly hostile to all things American, both have their own vaccines and are not interested in any sort of quid pro quo with Washington.
 
Many of the poor portions of the world are out. In part, its an issue of economics and strategy. Its harsh to say but there is only so much that Bolivia or Niger can offer the United States. But just as important, it is about COVID itself. The people the virus tends to kill are over 65. In the world’s poorer countries, not all that many live that long. That hardly means coronavirus is something they can just take in stride, but the mass casualties we’ve seen in the advanced world just don’t occur within the younger-aged populations of the poorer parts of the developing world. And the niggling logistical issues remain; While the J&J formula can be distributed easily, it is the only one that can be – and even J&J needs a refrigerator cold chain.
 
India is probably out as well. Not because an Indo-American tie up wouldn’t be a solid idea, but because India has its own vaccine manufacturing capacity. In fact, India has its own vaccine diplomacy program that already stretches from Mongolia to Myanmar (if you have problems with China, you can probably count on New Delhi to help you out with vaccines).
 
That still leaves us with just under half the global population that are potential American vaccine diplomacy targets. I can’t tell you which countries TeamBiden will pick in which order. That will in part be determined by the new administration’s evolving priorities as well as the broader geopolitical environment in the last half of 2021. What I can do is lay out the options from cleanest to messiest:
 
The Five Eyes: Back in the 1950s the Americans worked with the Brits, Canadians, Australians and New Zealanders to build a globe-spanning intelligence collection system. We know that today as the Five Eyes. The five Anglo nations aren’t simply friends and allies, they are family, and it would stretch the mind for all not to be included in some degree of vaccine sharing. It was also be eeeeasy. After all, the UK is taking care of itself, and Canada is already first on America’s list. Combined, there are only 30 million Aussies and Kiwis; Supplying sufficient doses would be child’s play.
 
Japan and South Korea: Allies? Check. First World countries? Check. Major trading partners? Check. Excellent health infrastructure? Check. Wildly insufficient domestic vaccine manufacturing capacity? Check. Both the Japanese and Koreans loathed Donald Trump’s efforts to wring economic and security concessions out of them, but in the end, both had to give in. Biden has indicated zero inclinations to give back anything Trump secured. If anything, the Biden administration will demand more. Vaccine diplomacy is an excellent way to either secure more concessions in specific or salve the relationships in general.
 
Southeast Asia: There’s a brewing competition between China and the United States for influence throughout the region, making a broadscale vaccination program a useful tool. The problems are complexity and scope. There are some 650 million people in the region. It is also politically and strategically messy. A recent military coup in Myanmar and an aging military coup in Thailand suggest diplomatic complications. Singapore is wildly rich and can take care of itself. Indonesia is huge and poor and lacks basic infrastructure for upwards of one-third of its population. Laos and Cambodia are de facto Chinese satellites. Malaysia is…stuffy. The smartest target might prove to be the Philippines. Manila gets petulant from time to time if the United States doesn’t toss the Philippines sufficient financial bones. Vaccines could well scratch the itch for years to come.
 
Colombia and Chile: This pair – courtesy of long-time friendly trade and political relations – are the only South American countries to make the list. Vaccine diplomacy would be a cheap and easy way to firm up ties. It would also underline the broader region that there are indeed benefits to being part of America’s Friends & Family Plan.
 
Taiwan: The Biden administration is doubling down on every anti-China effort the Trump administration started. On the same day of the J&J-Merck announcement, the new U.S. Trade Representative, Katherine Tai, announced a broadscale legal effort to target pretty much everything China does as a matter of course: from genocide in Xinjiang to political repression in Hong Kong to forced labor to unfair state financing. The only thing I can think of that would piss Beijing off more than the United States providing Taiwan with all the vaccine it needs, would be if an American cabinet secretary accompanied the delivery (Defense Secretary Lloyd Austin would be a delightfully inflammatory choice).
 
The European Union: Phbbbt. The EU’s vaccination effort to this point has been a disaster. In part it is bad luck: Unlike the US or Canada or the UK, most of the formulas the Continental Europeans backed didn’t work out. In part it is a bad approach: the EU started its negotiations with would-be manufacturers late and the Euros made price-haggling their top priority, so Europe is at the back of the line when it comes to deliveries. In part it was bad politics: the European Commission briefly – and extraordinarily stupidly – threatened border and trade relations with countries that had better vaccination planning. But mostly it is simply that Europe didn’t have any health capacity at the EU level and so it is literally making up everything as it goes.
 
And so, the rest of the world is pulling ahead. Post-Brexit UK is nearly the best in the world with vaccinations (which is galling enough to the Europeans), but economically devastated and strategically isolated Serbia has already vaccinated 20% of its population. The top-in-class EU country – Denmark – is barely half that far.
 
As a Europhile, I find it disheartening not only how badly the EU is doing, but how quickly EU members of all wealth levels are losing faith. Hungary, Austria and Denmark have opted to stop waiting for the EU to get its act together and so have entered separate agreements with Russia and Israel. The Netherlands, Sweden, Finland and Poland are likely to follow similar paths.
 
These disconnects provide a wealth of options for the Biden administration.

  • It could attempt a straight up vaccines-for-NATO program in an effort to achieve with honey what Trump attempted with vinegar: getting the Europeans to take their security seriously and actually commit financial resources to their own defense.
     
  • It could trade hundreds of millions of doses to the EU in exchange for broadscale trade concessions from the entire bloc. Aerospace and agriculture are two particularly sticky logjams that could benefit from vaccine-related lubrication.
     
  • It could bypass the EU and NATO completely and instead choose to target specific strategic partners in order to lock down long-term security agreements (Italy and Spain come to mind) to the detriment of any European defense planning.
     
  • It could trade vaccines for following the American lead against all things China. Say good-bye to the EU’s recent investment bilateral with Beijing?
     
  • It could provide the doses to the United Kingdom to distribute to Europe as London sees fit, an action which would reduce any bad PR to first derivative effects and give the United States a leg up in post-Brexit trade talks with the Brits.
     
  • It could toss enough vaccine into Germany’s lap to inoculate the German population but allow Berlin to decide how to distribute the doses. If the doses go to Germans, the EU would politically implode; but if the Germans distribute them to Europe, the German government would fall.

Best yet, the United States is likely to have so many doses by the fourth quarter, it could attempt multiple options.


If you enjoy our free newsletters, the team at Zeihan on Geopolitics asks you to consider donating to Feeding America.

The economic lockdowns in the wake of COVID-19 left many without jobs and additional tens of millions of people, including children, without reliable food. Feeding America works with food manufacturers and suppliers to provide meals for those in need and provides direct support to America’s food banks.

Food pantries are facing declining donations from grocery stores with stretched supply chains. At the same time, they are doing what they can to quickly scale their operations to meet demand. But they need donations – they need cash – to do so now.

Feeding America is a great way to help in difficult times.

The team at Zeihan on Geopolitics thanks you and hopes you continue to enjoy our work.

DONATE TO FEEDING AMERICA

Infographic: US Causes of Death and Vaccine Safety

The United States approved a third COVID-19 vaccine—the latest from Johnson and Johnson—for use, offering up millions of more doses for Americans. As I stated in my video yesterday, vaccines should be available on demand by mid-April. The speed at which vaccines have been developed is nothing short of miraculous, but so too is the high rate of efficacy and safety afforded by all approved vaccine options. In nearly all cases, serious COVID disease—hospital stays, intubation, and death—from COVID are prevented. And there have been no cases found where receiving the vaccine was directly attributable to death. Not. One. This is an astounding track record against the backdrop of a 12-month period when over 500,000 Americans have died because of COVID-19. In just a few short months, much of the US will have turned the corner, even as other countries struggle to secure vaccine supplies to battle against new and emerging viral variants.


If you enjoy our free newsletters, the team at Zeihan on Geopolitics asks you to consider donating to Feeding America.

The economic lockdowns in the wake of COVID-19 left many without jobs and additional tens of millions of people, including children, without reliable food. Feeding America works with food manufacturers and suppliers to provide meals for those in need and provides direct support to America’s food banks.

Food pantries are facing declining donations from grocery stores with stretched supply chains. At the same time, they are doing what they can to quickly scale their operations to meet demand. But they need donations – they need cash – to do so now.

Feeding America is a great way to help in difficult times.

The team at Zeihan on Geopolitics thanks you and hopes you continue to enjoy our work.

DONATE TO FEEDING AMERICA

Video Dispatch: Vaccines, Variants, and What’s Next

Here’s some good news for a change: the US has approved its third vaccine option–Johnson and Johnson’s single-dose shot–even as total daily vaccinations with the two-shot Moderna and Pfizer vaccines continues to rise. With additional supply and the real strides being made in pharmacies and doctors’ offices across the country, most Americans should be able to get a vaccine on demand by mid-April. 

For the rest of the world, the story is not nearly as rosy. Supply bottlenecks coupled with new and emerging variants mean that  the United States can start easing its lockdowns considerably before summer. In Europe and beyond, the threat of a fourth wave will continue to linger.


If you enjoy our free newsletters, the team at Zeihan on Geopolitics asks you to consider donating to Feeding America.

The economic lockdowns in the wake of COVID-19 left many without jobs and additional tens of millions of people, including children, without reliable food. Feeding America works with food manufacturers and suppliers to provide meals for those in need and provides direct support to America’s food banks.

Food pantries are facing declining donations from grocery stores with stretched supply chains. At the same time, they are doing what they can to quickly scale their operations to meet demand. But they need donations – they need cash – to do so now.

Feeding America is a great way to help in difficult times.

The team at Zeihan on Geopolitics thanks you and hopes you continue to enjoy our work.

DONATE TO FEEDING AMERICA

Infographic: SARS-COV-2 and its Noteworthy Variants

Much of current media coverage of the corona virus is focusing on the issue of variants of SARS-COV-2, the virus that causes COVID-19. Here in the United States, we’re currently in a race against time in our attempts to vaccinate the population and significantly slow—or stop—transmission before one of the nastier variants hits our shores.

Variants are mutations of a virus that changes how the virus interacts with our bodies. Chances are most of us have seen illustrations of the corona virus by now—a ball covered in spikey appendages. The protein spikes are how the corona virus attaches itself to our cells, and where our immune system attaches itself to the virus. In the UK and likely South Africa and Brazil, the local variants have mutations making the virus not only easier to attach to our cells (and making it more infectious), but also harder for our immune systems to combat (making it more resistant to vaccines and natural immunity). In the UK, there is evidence that their particular variant is deadlier, too.

What we know about the UK variant, and what we still don’t understand about variants in Brazil, South Africa, and California boils down to genomic sequencing. The UK has invested heavily in recent months into expanding their already better-than-most genomic sequencing and tracking of viral variants. They’ve put in the yeoman’s work of tracking changes to SARS-COV-2’s protein spike exterior and how changes in these proteins impact our relationship to the virus.

In the rest of the world, the tracking and identification of variants has been hampered by the lack of rigorous, coordinated international sampling and sequencing—an effort such as the US might have spearheaded in the past—and the lack of robust testing in the US itself. Some states are improving sampling and genomic sequencing efforts on their own, such as California, which announced that a local variant was spreading rapidly in January 2021. Anecdotal evidence is starting to come in, but as of this writing we still do not know the full extent of what the California variant will mean for regional populations.

COVID, Vaccines, and the Road to Recovery

Let’s begin with the bad news.
 
The United States has not seen any meaningful expansion of coronavirus testing since the November 2020 fall-off (see the stall in the purple graph below). Such suggests the United States is undertesting by at least two-thirds.
 
New testing and new positive results (red) have not been a useful measure of anything for roughly three months now. We are so late in the epidemic at this point that a testing recovery is unlikely. This is very bad. Without sufficient testing and accurate data, it is impossible for any jurisdiction to plan for anything. Instead, the first sign that something is wrong is that hospitals fill up. At that point, the issue is no longer prevention, or even planning, but instead crisis mitigation.

So, sadly and unsurprisingly, the figure to watch has become hospitalizations and only hospitalizations (blue). Hospitalizations have been, in a word, heartbreaking. They have been over double their August peak for some time.

But but but BUT we are very clearly past the peak in hospitalizations caused by the Thanksgiving and Christmas surges. It even appears *fingers crossed* that deaths (grey) have peaked as well. This is the second-best news we have had during the past six months of the epidemic.

The even-better news is there are now three coronavirus vaccines in various stages of dispersal. All three – Pfizer, Moderna, and AstraZeneca – are rapidly ramping up manufacturing. And more are coming. Novavax and Johnson & Johnson’s formulas will be added to the mix in the weeks to come.

This all raises a lot of questions:

  • How soon will we be able to start quietly dreaming of herd immunity and a “normal” world?
     
  • What are the differences among the vaccines and how will those differences play out?
     
  • Which countries and economic sectors are likely to recover first, and how quickly?
     
  • How will the new coronavirus variants percolating in the United Kingdom, Brazil and South Africa impact the broader picture?

Please join Zeihan on Geopolitics on February 9 for COVID, Vaccines, and the Road to Recovery, a webinar and Q&A session tackling these questions and more. Registration information and more at the link below.

Register for COVID, Vaccines, and the Road to Recovery

Video Dispatch: Of Vaccines and the New Year

COVID-19’s Thanksgiving surge is upon us. We’re now facing record cases, hospitalizations and deaths and will continue at least through the end of January 2021.
 
But there is some very good news out there as regards vaccines. There is a light at the end of the tunnel. It is not a train. Let us break down what’s happening and what’s about to happen so you can make sense of and plans the New Year.


If you enjoy our free newsletters, the team at Zeihan on Geopolitics asks you to consider donating to Feeding America.

The economic lockdowns in the wake of COVID-19 left many without jobs and additional tens of millions of people, including children, without reliable food. Feeding America works with food manufacturers and suppliers to provide meals for those in need and provides direct support to America’s food banks.

Food pantries are facing declining donations from grocery stores with stretched supply chains. At the same time, they are doing what they can to quickly scale their operations to meet demand. But they need donations – they need cash – to do so now.

Feeding America is a great way to help in difficult times.

The team at Zeihan on Geopolitics thanks you and hopes you continue to enjoy our work.

DONATE TO FEEDING AMERICA

Video Dispatch: Good News on the Vaccine Front

It is a rare bit of good news we have to share in general, and especially in 2020, so we’re taking it! Less than a year after the broader world found out about an emerging new coronavirus epidemic in Wuhan we now have two very promising vaccine options applying for emergency use authorization in the United States with more around the corner. There are some potential hiccups looming, mostly around manufacturing and distribution and state-level decisions around prioritizing who gets first and second round access to the vaccine. But, the hardest parts of the process are done and it’s getting easier to see the light at the end of the tunnel.


If you enjoy our free newsletters, the team at Zeihan on Geopolitics asks you to consider donating to Feeding America.

The economic lockdowns in the wake of COVID-19 left many without jobs and additional tens of millions of people, including children, without reliable food. Feeding America works with food manufacturers and suppliers to provide meals for those in need and provides direct support to America’s food banks.

Food pantries are facing declining donations from grocery stores with stretched supply chains. At the same time, they are doing what they can to quickly scale their operations to meet demand. But they need donations – they need cash – to do so now.

Feeding America is a great way to help in difficult times.

The team at Zeihan on Geopolitics thanks you and hopes you continue to enjoy our work.

DONATE TO FEEDING AMERICA